Výsledky vyhledávání - "Pierluigi Piovano"

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

Autor: Giorgio Galanti, Roberto Tarquini, Valentina Guarneri, Sandro Barni, Lorenzo Livi, Pierluigi Piovano, Giuseppe Barletta, Francesca Martella, Francesca Terziani, Carmelo Bengala, Giacomo Allegrini, Agnese Vannini, Paolo Marchetti, Domenico Amoroso, Isacco Desideri, Mario Airoldi, Giuseppe Curigliano, Icro Meattini, Carlotta Becherini

Publikováno v: Medical oncology (Northwood, London, England). 34(5)

Over the years, thanks to the addition of new generation systemic agents, as well as the use of more advanced and precise radiotherapy techniques, it was able to obtain a high curability rate for breast cancer. Anthracyclines play a key role in the t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782a1ed47810f4289a62093c6aa0424a
https://pubmed.ncbi.nlm.nih.gov/28364270

Zobrazit plný text záznamu

Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion

Autor: Nicola Silvestris, Marcella Occelli, Elena Fea, Ida Colantonio, Alessandro Mozzicafreddo, Pierluigi Piovano, Gianmauro Numico, Antonella Cristofano, Marco Merlano, Marco Sicuro

Publikováno v: Medicine

Malignant pericardial effusion (MPE) is a serious complication of several cancers. The most commonly involved solid tumors are lung and breast cancer. MPE can give rise to the clinical picture of cardiac tamponade, a life threatening condition that n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39e12163c431074f4adf2a4e68c59406
https://doi.org/10.1097/md.0000000000003273

Zobrazit plný text záznamu

Double KRAS and BRAF mutations in colorectal cancer in a single oncologic department series

Autor: Giuseppe Spinoglio, Narciso Mariani, Federica Grosso, Marco Galliano, Maura Rossi, Vittorio Fusco, Silvia Zai, Sara Orecchia, Elisa Bennicelli, Roberta Libener, Pamela Guglielmini, Pierluigi Piovano

Publikováno v: Journal of Clinical Oncology. 31:e14657-e14657

e14657 Background: KRAS and BRAF mutations have prognostic and predictive value in colorectal cancer and are predominantly mutually exclusive. Only a few cases of double mutations (DM) have been reported so far but the actual incidence and presumed r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf5f97629e28728ef0a1c585fcec2335
https://doi.org/10.1200/jco.2013.31.15_suppl.e14657

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání